Chemical Perspective

Dr, Mandar Shah is CEO of a start=up drug business, Prima Innovations. Prima is developing a new drug the relieves pain without having to depend on interactions with the brain. Rather, it acts on a direct pathway at the pain's source w/o depending on the brain. This means that patients do not suffer from the brain fog that characterizes standard pain relievers.

Dave Raine describes the work he is doing within his company, MIM Robots. Dave applies his background in software engineering to create robots that are self-teaching using MIM AI software. Dave discusses the implications of his work, and future paths.

In this episode, Dr. Joel Shertok interviews Jerry Grunewald about his extensive career in the chemical industry, sharing insights on operations, safety, technological change, and leadership lessons learned along the way.

In this podcast, Dr. Joel Shertok interviews Brian Haney about cost segregation, a tax strategy that allows property owners to accelerate depreciation on commercial buildings, leading to significant tax benefits. The conversation covers the basics of cost segregation, its benefits, additional services offered, and real-life success stories that highlight the financial impact of these strategies.

In this podcast episode, Joel Shertok interviews Justin Duplantis from Zedlbit to explore the field of bioinformatics. Justin explains the intersection of math, biology, and computer science in analyzing large genetic datasets. He discusses Zedlbit's role in the research lifecycle, their business model, and how they assist clients with bioinformatics needs.

The conversation also touches on the impact of AI in the field, the skills necessary for success, and the importance of continuous improvement in a rapidly evolving industry. Justin shares personal insights about mentorship and his aspirations for the future.